{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T08:19:35Z","timestamp":1742804375378},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s40258-019-00533-z","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T05:29:06Z","timestamp":1573709346000},"page":"127-137","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Forecasting Ontario Oncology Drug Expenditures: A Hybrid Approach to Improving Accuracy"],"prefix":"10.1007","volume":"18","author":[{"given":"Paula M.","family":"Murray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf A.","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Ieraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmett","family":"Borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Sniekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Vahit","family":"Esensoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"key":"533_CR1","unstructured":"Ministry of Health and Long-Term Care (MOHLTC). Executive Officer Communications\u2014Ontario Public Drug Programs (OPDP) [Internet]. 2019 [cited 2019 Sep 30]. http:\/\/health.gov.on.ca\/en\/pro\/programs\/drugs\/publications\/opdpataglance\/. Accessed 30 Sept 2019."},{"issue":"Supplement 1","key":"533_CR2","first-page":"e11","volume":"23","author":"RD Naipaul","year":"2016","unstructured":"Naipaul RD, Beca J, Gavura S. 19: Shifting trends: an analysis of IV and take-home cancer drug use and public spending in Ontario. J Popul Ther Clin Pharmacol. 2016;23(Supplement 1):e11.","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"533_CR3","unstructured":"Cancer Care Ontario (CCO). New drug funding program (NDFP) [Internet]. Cancer Care Ont. 2019 [cited 2019 Sep 30]. https:\/\/www.cancercareontario.ca\/en\/Funding\/New_Drug_Funding_Program. Accessed 30 Sept 2019."},{"key":"533_CR4","unstructured":"Cancer Care Ontario (CCO). Cancer treatments\u2014drug formulary [Internet]. Cancer Care Ont. 2019 [cited 2019 Sep 30]. https:\/\/www.cancercareontario.ca\/en\/drugformulary\/drugs. Accessed 30 Sept 2019."},{"key":"533_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0169-2070(92)90121-O","volume":"8","author":"BJ Dangerfield","year":"1992","unstructured":"Dangerfield BJ, Morris JS. Top-down or bottom-up: aggregate versus disaggregate extrapolations. Int J Forecast. 1992;8:233\u201341.","journal-title":"Int J Forecast."},{"key":"533_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s40273-013-0082-1","volume":"31","author":"P O\u2019Neill","year":"2013","unstructured":"O\u2019Neill P, Mestre-Ferrandiz J, Puig-Peiro R, Sussex J. Projecting expenditure on medicines in the UK NHS. PharmacoEconomics. 2013;31:933\u201357.","journal-title":"PharmacoEconomics."},{"key":"533_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1472-6963-10-128","volume":"10","author":"B Wettermark","year":"2010","unstructured":"Wettermark B, Persson ME, Wilking N, Kalin M, Korkmaz S, Hjemdahl P, et al. Forecasting drug utilization and expenditure in a metropolitan health region. BMC Health Serv Res. 2010;10:128.","journal-title":"BMC Health Serv Res."},{"key":"533_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2146\/ajhp180138","volume":"75","author":"GT Schumock","year":"2018","unstructured":"Schumock GT, Stubbings J, Wiest MD, Li EC, Suda KJ, Matusiak LM, et al. National trends in prescription drug expenditures and projections for 2018. Am J Health Syst Pharm. 2018;75:1023\u201338.","journal-title":"Am J Health Syst Pharm."},{"key":"533_CR9","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1080\/00036846.2011.633895","volume":"45","author":"SP Thiebaut","year":"2013","unstructured":"Thiebaut SP, Barnay T, Ventelou B. Ageing, chronic conditions and the evolution of future drugs expenditure: a five-year micro-simulation from 2004 to 2029. Appl Econ. 2013;45:1663\u201372.","journal-title":"Appl Econ."},{"key":"533_CR10","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1377\/hlthaff.2011.0662","volume":"30","author":"SP Keehan","year":"2011","unstructured":"Keehan SP, Sisko AM, Truffer CJ, Poisal JA, Cuckler GA, Madison AJ, et al. National health spending projections through 2020: economic recovery and reform drive faster spending growth. Health Aff (Millwood). 2011;30:1594\u2013605.","journal-title":"Health Aff (Millwood)."},{"key":"533_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.sapharm.2009.12.002","volume":"7","author":"Y Ferrand","year":"2011","unstructured":"Ferrand Y, Kelton CML, Guo JJ, Levy MS, Yu Y. Using time-series intervention analysis to understand U.S. Medicaid expenditures on antidepressant agents. Res Soc Adm Pharm. 2011;7:64\u201380.","journal-title":"Res Soc Adm Pharm."},{"key":"533_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jval.2014.08.2201","volume":"17","author":"GG Schoch","year":"2014","unstructured":"Schoch GG, Blank S, Tamminga M, Steimle T, Stargardt T. Forecasting Outpatient pharmaceutical expenditure for cancer treatment in Germany. Value Health J Int Soc Pharmacoecon Outcomes Res. 2014;17:1.","journal-title":"Value Health J Int Soc Pharmacoecon Outcomes Res."},{"issue":"1","key":"533_CR13","doi-asserted-by":"publisher","first-page":"23738","DOI":"10.3402\/jmahp.v2.23738","volume":"2","author":"D Urbinati","year":"2014","unstructured":"Urbinati D, R\u00e9muzat C, Kornfeld \u00c5, Vataire AL, Cetinsoy L, Aball\u00e9a S, Mzoughi O, Toumi M. EU pharmaceutical expenditure forecast. J Mark Access Health Policy. 2014;2(1):23738.","journal-title":"J Mark Access Health Policy."},{"issue":"1","key":"533_CR14","doi-asserted-by":"publisher","first-page":"24082","DOI":"10.3402\/jmahp.v2.24082","volume":"2","author":"AL Vataire","year":"2014","unstructured":"Vataire AL, Cetinsoy L, Aball\u00e9a S, R\u00e9muzat C, Urbinati D, Kornfeld \u00c5, Mzoughi O, Toumi M. Novel methodology for pharmaceutical expenditure forecast. J Mark Access Health Policy. 2014;2(1):24082.","journal-title":"J Mark Access Health Policy."},{"key":"533_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0305-0483(01)00062-7","volume":"30","author":"P Goodwin","year":"2002","unstructured":"Goodwin P. Integrating management judgment and statistical methods to improve short-term forecasts. Omega. 2002;30:127\u201335.","journal-title":"Omega."},{"key":"533_CR16","first-page":"2523","volume":"32","author":"L Yu","year":"2005","unstructured":"Yu L, Wang S, Lai KK. A novel nonlinear ensemble forecasting model incorporating GLAR and ANN for foreign exchange rates. Appl Neural Netw. 2005;32:2523\u201341.","journal-title":"Appl Neural Netw."},{"key":"533_CR17","first-page":"3","volume":"170","author":"G Armano","year":"2005","unstructured":"Armano G, Marchesi M, Murru A. A hybrid genetic-neural architecture for stock indexes forecasting. Comput Intell Econ Financ. 2005;170:3\u201333.","journal-title":"Comput Intell Econ Financ."},{"key":"533_CR18","first-page":"956","volume":"72","author":"M Khashei","year":"2009","unstructured":"Khashei M, Bijari M, Raissi Ardali GA. improvement of auto-regressive integrated moving average models using fuzzy logic and artificial neural networks (ANNs). Brain Inspired Cogn Syst BICS 2006 Interplay Nat Artif Comput IWINAC 2007. 2009;72:956\u201367.","journal-title":"Brain Inspired Cogn Syst BICS 2006 Interplay Nat Artif Comput IWINAC 2007"},{"key":"533_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.omega.2004.07.024","volume":"33","author":"P-F Pai","year":"2005","unstructured":"Pai P-F, Lin C-S. A hybrid ARIMA and support vector machines model in stock price forecasting. Omega. 2005;33:497\u2013505.","journal-title":"Omega."},{"key":"533_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0925-2312(01)00702-0","volume":"50","author":"GP Zhang","year":"2003","unstructured":"Zhang GP. Time series forecasting using a hybrid ARIMA and neural network model. Neurocomputing. 2003;50:159\u201375.","journal-title":"Neurocomputing."},{"key":"533_CR21","unstructured":"R Core Team. Vienna, Austria: R Foundation for Statistical Computing; 2016. https:\/\/www.R-project.org\/. Accessed 28 Aug 2019."},{"key":"533_CR22","unstructured":"Hyndman R. 2016. http:\/\/github.com\/robjhyndman\/forecast. Accessed 28 Aug 2019."},{"issue":"Supplement 5","key":"533_CR23","first-page":"2","volume":"25","author":"R Naipaul","year":"2019","unstructured":"Naipaul R, Beca J, Gavura S. 03-The effectiveness of Ontario\u2019s generic pricing polices for intravenous chemotherapy. J Oncol Pharm Practice 2019;25(Supplement 5):2","journal-title":"J Oncol Pharm Practice"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-019-00533-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40258-019-00533-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-019-00533-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:25:05Z","timestamp":1605227105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40258-019-00533-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["533"],"URL":"https:\/\/doi.org\/10.1007\/s40258-019-00533-z","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]},"assertion":[{"value":"14 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Paula Murray, Yusuf Shalaby, Luciano Ieraci, Emmett Borg, Daphne Sniekers, Ali Vahit Esensoy and Jessica Arias have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal rights"}},{"value":"No funding from external sources was provided for this work. The study was supported by CCO. Parts of this material are based on data and information provided by CCO. The opinions, results, views and conclusions reported in this paper are those of the authors and not those of CCO.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}